Suppr超能文献

特布他林、多巴酚丁胺或异丙肾上腺素作用后大鼠唾液腺的钙和去甲肾上腺素水平

Calcium and norepinephrine levels of rat salivary glands after terbutaline, dobutamine or isoproterenol.

作者信息

Schneyer C A

出版信息

J Auton Nerv Syst. 1985 Oct;14(2):191-200. doi: 10.1016/0165-1838(85)90075-x.

Abstract

Present data show that a dose-related increase in calcium concentration [Ca] of submandibular glands of rat occurred after 6 days of twice daily administration of 25, 50 or 75 mg/kg b. wt. doses of the beta 1-adrenergic agonist, dobutamine, or the beta 2-adrenergic agonist, terbutaline. The beta 1-adrenergic receptor was responsible for mediation of these changes with both agonists since the effects of either agonist were prevented when a 10 mg/kg dose of the beta 1-antagonist, atenolol, was injected 20 min prior to the agonist, and the increase induced by either agonist was not prevented when the beta 1-adrenergic antagonist, butoxamine, was given prior to each agonist. Dobutamine caused more marked increases in [Ca] than did terbutaline. The parotid gland, however, showed a decrease with both agonists, and that caused by dobutamine was greater than that caused by terbutaline. Neither antagonist had any effect on the agonist-induced changes in the parotid gland. Reasons for the differences in response of the two glands are suggested. It does not appear, however, that, as suggested previously, the increase in the [Ca] of the submandibular gland is dependent on depletion of glandular levels of norepinephrine (NE). Of the agonists, only dobutamine caused a decrease in glandular concentration of NE, as well as total NE of the gland. With isoproterenol (ISO), NE concentration of parotid and submandibular was reduced, but with terbutaline only that of parotid was reduced. changes in total glandular NE were not found in either gland with either ISO or terbutaline. Thus, the decrease in concentration was a consequence of the increased mass of gland. With cyclocytidine (CC), both NE concentration and total NE were reduced, even though gland size increased. With reserpine (RES), NE concentration as well as total NE were markedly reduced (87-90%), and no change in gland size occurred. It is suggested, on the basis of present data, that prolonged activation of beta 1-adrenoceptors is the cause of the calcium accumulation, and that reduction in NE is not the cause of the calcium increase, but may only be a coincident event. Even with sympathectomy (here induced by reserpine), activation of beta-receptors over a long period of time is suggested as the cause of the calcium change, not the depletion of NE. The present data also provide the first evidence that CC causes NE depletion.

摘要

目前的数据表明,大鼠下颌下腺在每日两次给予25、50或75mg/kg体重剂量的β1 - 肾上腺素能激动剂多巴酚丁胺或β2 - 肾上腺素能激动剂特布他林6天后,钙浓度[Ca]出现剂量相关的增加。β1 - 肾上腺素能受体介导了这两种激动剂引起的这些变化,因为当在给予激动剂前20分钟注射10mg/kg剂量的β1 - 拮抗剂阿替洛尔时,两种激动剂的作用均被阻断,而当在每种激动剂之前给予β1 - 肾上腺素能拮抗剂布托沙明时,两种激动剂诱导的增加并未被阻断。多巴酚丁胺引起的[Ca]增加比特布他林更明显。然而,腮腺对两种激动剂均表现出降低,且多巴酚丁胺引起的降低大于特布他林引起的降低。两种拮抗剂对激动剂诱导的腮腺变化均无任何影响。文中提出了两个腺体反应差异的原因。然而,此前曾有人提出下颌下腺[Ca]的增加依赖于腺体内去甲肾上腺素(NE)水平的耗竭,但目前的数据似乎并非如此。在这些激动剂中,只有多巴酚丁胺导致腺体内NE浓度以及腺体总NE含量降低。使用异丙肾上腺素(ISO)时,腮腺和下颌下腺的NE浓度降低,但使用特布他林时,仅腮腺的NE浓度降低。使用ISO或特布他林时,在两种腺体中均未发现腺体总NE的变化。因此,浓度的降低是腺体质量增加的结果。使用环胞苷(CC)时,即使腺体大小增加,NE浓度和总NE含量均降低。使用利血平(RES)时,NE浓度以及总NE含量均显著降低(87 - 90%),且腺体大小无变化。根据目前的数据表明,β1 - 肾上腺素能受体的长期激活是钙积累的原因,NE的减少不是钙增加的原因,而可能只是一个巧合事件。即使进行了交感神经切除术(此处由利血平诱导),长时间的β受体激活被认为是钙变化的原因,而非NE的耗竭。目前的数据还首次提供了CC导致NE耗竭的证据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验